Vascular endothelial growth factor–stimulated endothelial cells promote adhesion and activation of platelets
Open Access
- 15 December 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (13), 4216-4221
- https://doi.org/10.1182/blood.v96.13.4216
Abstract
Coagulation abnormalities, including an increased platelet turnover, are frequently found in patients with cancer. Because platelets secrete angiogenic factors on activation, this study tested the hypothesis that platelets contribute to angiogenesis. Stimulation with vascular endothelial growth factor (VEGF, 25 ng/mL) of human umbilical vein endothelial cells (HUVECs) promoted adhesion of nonactivated platelets 2.5-fold. In contrast, stimulation of HUVECs with basic fibroblast growth factor (bFGF) did not promote platelet adhesion. By blocking tissue factor (TF) activity, platelet adhesion was prevented and antibodies against fibrin(ogen) and the platelet-specific integrin, αIIbβ3, inhibited platelet adhesion for 70% to 90%. These results indicate that VEGF-induced platelet adhesion to endothelial cells is dependent on activation of TF. The involvement of fibrin(ogen) and the αIIbβ3 integrin, which exposes a high-affinity binding site for fibrin(ogen) on platelet activation, indicates that these adhering platelets are activated. This was supported by the finding that the activity of thrombin, a product of TF-activated coagulation and a potent platelet activator, was required for platelet adhesion. Finally, platelets at physiologic concentrations stimulated proliferation of HUVECs, indicative of proangiogenic activity in vivo. These results support the hypothesis that platelets contribute to tumor-induced angiogenesis. In addition, they may explain the clinical observation of an increased platelet turnover in cancer patients. Platelets may also play an important role in other angiogenesis-dependent diseases in which VEGF is involved, such as diabetes and autoimmune diseases.This publication has 23 references indexed in Scilit:
- Targeting Vascular Endothelial Growth Factor Blockade: Ascites and Pleural Effusion FormationThe Oncologist, 2000
- Evidence that platelets promote tube formation by endothelial cells on matrigelBritish Journal of Pharmacology, 1998
- Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbαThe Journal of Experimental Medicine, 1998
- Acidic and Basic Fibroblast Growth Factors Suppress Transcriptional Activation of Tissue Factor and Other Inflammatory Genes in Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Prognostic significance of thrombocytosis in patients with primary lung cancerEuropean Respiratory Journal, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.JCI Insight, 1994
- Tumors: Wounds That Do Not HealThe New England Journal of Medicine, 1986
- Role of Platelets and Fibrin in the Healing SequenceAnnals of Surgery, 1982
- Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences of the United States of America, 1968